There has been a strong policy emphasis over the past decade on optimising patientcentred care and reducing general practitioners' (GPs') workload by extending community pharmacy services and collaboration between pharmacists and GPs. Our aim was to review current evidence of pharmacists' and GPs' views of extended community pharmacy services and pharmacists' roles in the United Kingdom (UK). A systematic review was undertaken looking at UK studies investigating pharmacists' and/or Following the application of inclusion/exclusion criteria, the quality of papers was critically analysed, findings were extracted into a grid and subjected to narrative synthesis following thematic analysis. The search strategy yielded a total of 4,066 unique papers from which 60 were included. Forty-seven papers covered pharmacists' views, nine combined both pharmacists' and GPs' views and four covered GPs' views.
| INTRODUC TI ON
Healthcare organisations face a progressive increase in patient demand (Abbing, 2016; Baird, Charles, Honeyman, Maguire, & Das, 2016) . The shifting emphasis towards primary healthcare has led to a considerable increase in workload pressure on general practitioners (GPs) (Baird et al., 2016; Department of Health, 2012; NHS England, 2016) . As a result, policy makers have emphasised the need to moderate primary care demands via innovative approaches using alternative healthcare channels (NHS England, 2013 , Pharmacy Voice, 2016 . As providers of primary care, community pharmacies are accessible and convenient, offering long opening hours and nonappointment-based services (NHS England., 2017 , Pharmacy Voice, 2016 , leading policy makers in the UK (Department of Health, 2008 , NHS England, 2013 and other countries (Agomo, 2012; Houle, Grindrod, Chatterley, & Tsuyuki, 2014) to promote the expansion of community pharmacy services to relieve existing pressures in general practice.
In recognition of this, the UK National Health Service revised the community pharmacy contractual framework for England and Wales in 2005 followed by Scotland in 2006. The revised contracts implemented novel reimbursement structures for a range of public health and medicines-related services (Pharmacy Voice, 2016) . In England, the revised contractual framework consists of three types of service: "essential", "advanced" and "locally commissioned". "Essential services" cover traditional services provided by all community pharmacies (i.e. dispensing medications/appliances, repeat dispensing and signposting). "Advanced services" focus on medication reviews conducted by pharmacists in the form of one-to-one consultations.
"Locally commissioned services" include a wide range of medication and public health services such as minor ailments management, lifestyle advice, substance misuse and sexual health services (Agomo, 2012) . To preserve patient privacy and confidentiality, consultation rooms became a prerequisite for community pharmacies subject to specific privacy requirements . Similar novel ser- (White, Klinner, & Carter, 2012) and New Zealand (Central TAS, 2014) .
Despite these reforms, there have been concerns regarding the provision and quality of extended pharmacy services (Bush, Langley, & Wilson, 2009; McDonald, Cheraghi-Sohi, Sanders, & Ashcroft, 2010) . Moreover, with evidence of low public uptake and awareness, demand for some of these services has been questionable (Eades, Ferguson, & O'Carroll, 2011; Famiyeh & McCarthy, 2017; Hindi, Schafheutle, & Jacobs, 2017) . Furthermore, there have been concerns over the retail context of community pharmacies introducing structural and organisational barriers to integration between community pharmacies and GP practices Royal Pharmaceutical Society, 2015) . Consequently, pharmacists have been sceptical towards role expansion (Anderson, Blenkinsopp, & Armstrong, 2003; Eades et al., 2011; Hall, Donovan, & Wilkes, 2018) and GPs have been reluctant to accept extended services despite their potential to reduce their pressure and workload (Dhillon, Hattingh, Stafford, & Hoti, 2015; Hossain et al., 2017; McGrath et al., 2010; Smith, Cannon-Breland, & Spiggle, 2014) .
Recently, the UK government stated their intention to further extend community pharmacy services and implement new strategies to strengthen lines of communication between community pharmacies and GP practices (Department of Health, 2016 , NHS England., 2017 . In line with these recent policy changes, it is important to understand both pharmacists' and GPs' views of community pharmacy services to ascertain the extent to which they may become integrated into the patient pathway.
The aim of this article was to review current evidence of pharmacists' and GPs' perspectives regarding extended community pharmacy services and pharmacists' roles in the UK.
| ME THODS
The methods used for this study followed the key principles for systematic reviews (Petticrew & Roberts, 2006) and used narrative approach to report findings in a descriptive manner. This approach was particularly insightful for synthesising disparate evidence to inform healthcare policy making (Mays, Pope, & Popay, 2005) .
What is known about this topic
• Policy makers have been promoting the expansion of community pharmacy services to relieve existing pressures in general practice.
• There is evidence of low public uptake and awareness for these extended services with the retail context of community pharmacies introducing barriers to successful implementation and integration.
What this paper adds
• Pharmacists were optimistic about the potential value of extended services, while GPs were more cautious towards their implementation.
• GPs' awareness of community pharmacy services was low and collaboration with pharmacists remain poor despite the introduction of these services.
• This review highlights the need to incentivise joint working between community pharmacists and GPs to achieve better integration within the patient's primary care pathway.
TA B L E 1 Search terms used for the review

Inclusion criteria Exclusion criteria
Setting: Community pharmacy (Porteous & Bond, 2005) Questionnaire 27 GPs Pharmacistmanaged repeat dispensing system To collect data on GPs' experiences of the new repeat dispensing system The system was liked by GPs and most said they would prefer to provide this system or a modified version of it for their patients. Just over half of GPs (15/27, 56%) said that the relationship was not altered by the study. GPs did not like having to sign all three copies of the prescription. focused, opportunistic and dependent on the services they provided, rather than being patient centred and proactive. The barriers to providing self-care support were described as priority accorded to dispensing activities, the structure of the community pharmacy contract, lack of incentives to provide self-care support and patients' expectations and lack of awareness of community pharmacy's role in LTCs management. cists on the usefulness of dMUR referrals from hospital, the suitability of patients referred and overall views on the service. Seven (36.8%) felt that it was hard to engage patients with dMURs. Failure or inability of patients to attend the pharmacy was the most common barriers. Reasons for medication changes (n = 5) and indications for new medicines (n = 4) were the most common examples of extra information that would be useful on referral. Community pharmacists held positive opinions on the dMUR service and could see the benefit to patients. Pharmacists wanted more referrals but reported performing few dMURs outside this study. 
Attitudes towards
| Critical appraisal
The quality of papers included in the review was evaluated by the lead author using a nine-item checklist developed to appraise research from different paradigms (Hawker, Payne, Kerr, Hardey, & Powell, 2002) . These items included: abstract and title, introduction and aims, method and data, sampling, data analysis, ethics and bias, results, transferability or generalisability, implications and usefulness.
Papers were rated "Good" (4), "Fair" (3), "Poor" (2), "Very poor" (1) for each of the nine items. The authors of this appraisal tool did not suggest cut-offs for classifying the total quality of studies (Hawker et al., 2002) . Nonetheless, we used cut-offs suggested by researchers who previously used this checklist (Braithwaite, Herkes, Ludlow, Testa, & Lamprell, 2017; Lorenc et al., 2014) : 'low quality' (9-23 points), 'medium quality' (24-29 points) and 'high quality' (30-36 points). Overall quality of the literature was evaluated and classified on the basis of the total score (min=0, max=36) (see Table 3 ). Studies were not excluded based on quality, but the score helped to critically appraise findings.
| RE SULTS
| Study selection
After removing duplicates, a total of 4,066 papers were subjected to initial screening. 601 papers were assessed for eligibility via full-text reading. Of these, 58 papers were included in the review and two additional papers were identified via Google Scholar (Figure 1 ).
| Study characteristics
The majority of study designs involved semistructured interviews (n = 31, 52%), questionnaire surveys (n = 17, 28%) and focus groups (n = 7, 12%). The remaining papers used either two or more qualitative methods (n = 3), mixed methods (n = 1) or discrete choice experiments (n = 1). More than half of the papers had been published in the last 4 years (n = 34, 57%). Forty-seven papers covered pharmacists' perspectives, four GPs' and nine both perspectives. Only three papers looked at perceptions on community pharmacy services in general (Al Hamarneh, Rosenthal, McElnay, & Tsuyuki, 2012; Butterworth et al., 2017; Scott, Bond, Inch, & Grant, 2007) , while the rest were service(s) specific (see Table 3 ).
| Critical appraisal
The overall quality of papers was medium (mean total score 26.1 ± 3.0) (see Table 3 ). However, most papers did not reflect on ethical issues (confidentiality, sensitivity and consent) and/or potential researcher biases. Only four qualitative papers acknowledged interviewer bias/reflexivity (Dabrera, Pinson, & Whiteman, 2011; Pumtong, Boardman, & Anderson, 2008; Savage, Blenkinsopp, Closs, & Bennett, 2013; Thomas et al., 2010) . The majority of papers did not justify sampling strategies/techniques used. All but six papers provided participant demographics. While the methodologies
Author(s) and year
Study design
Number of participants
Pharmacy service/role Brief description of the study aim
Key Findings
Theme(s) and subtheme(s)
Quality score (out of 36) (Twigg et al., 2017) Focus group 7 community pharmacists UK Pharmacy Care Plan service To describe the initial findings from the setup and delivery of a novel community pharmacy-based person-centred service Pharmacists could see the potential patient benefit and the extended role opportunities the service provided. Pharmacists were positive regarding the consultation skills training which had been provided and recognised the need to practise when they returned to the pharmacy in order to become competent at delivering the service. All of the pharmacists identified the difficulty with conducting the initial consultations with patients. They reported techniques to manage their workload by staging appointments over a longer period and asking for locum pharmacist cover to enable them to spend the time with patients. However, this cover was difficult to arrange and variable in availability. For these papers, eliciting pharmacist/GP perspectives was not the main component hence, reporting was minimal which produced low scores.
Attitudes towards
TA B L E 3 (Continued)
used were appropriate for all papers, some did not provide sufficient details on data collection. Some papers did not clearly explain how themes were derived and provided minimal details on statistical analysis. Findings were clearly stated for most papers and all but one paper explicitly stated implications to policy and/or practice.
| Thematic Analysis
Three overarching themes emerged from the data as components influencing service provision/quality in community pharmacies:
"attitudes towards services/roles", "community pharmacy organisations" and "external influences" (Figure 2 ). "Attitudes towards services" provided insights into the mindsets of pharmacists and GPs regarding extended pharmacy services. "Community pharmacy organisations" and "external influences" explored influences within and outside the pharmacy organisation respectively.
| Attitudes towards services/roles
This theme described how pharmacists and GPs perceived the concept of extended services and pharmacist roles in community pharmacies. This theme covered three subthemes: "awareness of services/roles", "perceived value of services/roles" and "pharmacists' competence and confidence".
| Awareness of services/roles
Pharmacists commonly voiced concerns over the lack of awareness of extended services particularly by patients and members of the public, but also among GPs. Studies reporting GP views confirmed their low awareness of extended services (Agomo, Portlock, & Ogunleye, 2017; Bradley, Ashcroft, & Noyce, 2012; Latif et al., 2016; Saramunee et al., 2014) . Pharmacists believed that a lack of Papers included in the review (n = 60)
well-defined roles made their responsibilities unclear to patients and GPs and led to services being perceived as crossing GP boundaries (Butterworth et al., 2017; Horsfield, Sheridan, & Anderson, 2011; Mantzourani, Richards, & Hughes, 2016; Morton, Pattison, Langley, & Powell, 2015) .
The public doesn't fully understand what the pharmacy has to offer. They see us as a supplier of medicines only.
(Pharmacist, Saramunee et al., 2014) 
| Perceived value of services/roles
Pharmacists voiced enthusiasm towards the concept of extended services, commonly referring to the accessibility/convenience of pharmacy services to patients and providing an alternative healthcare destination to GPs. Pharmacists in two studies mentioned potential financial benefits to patients (Butt & Ream, 2016; Pumtong et al., 2008) with one of these studies highlighting the importance of minor ailments to those in highly deprived areas who may not be able to afford over-the-counter medications (Pumtong et al., 2008) . Other patient benefits discussed were reassurance (Lucas & Blenkinsopp, 2015; Morecroft et al., 2015; Thomas et al., 2010; Urwin, Wright, Twigg, & McGough, 2016) , increased patient confidence (Urban, Rivers, & Morgan, 2008) and improved clinical outcomes (Campion, Hilton, & Irving, 2007; Latif & Boardman, 2008; Lucas & Blenkinsopp, 2015; Morecroft et al., 2015; Ogunbayo, Schafheutle, Cutts, & Noyce, 2015; Paudyal, Hansford, Scott Cunningham, & Stewart, 2010; Wells, Thornley, Boyd, & Boardman, 2014) .
They perceived the main benefit to GPs of extended pharmacy services was to reduce workload pressures (Agomo, Ogunleye, & Portlock, 2016a; Atkins et al., 2016; Morecroft et al., 2015; Pumtong et al., 2008) , freeing up GPs time to deal with more urgent matters (Heller, Johnstone, & Cameron, 2017; Morecroft et al., 2015) . In terms of their own benefit, most pharmacists viewed these services as an opportunity for role expansion/professional development, improving their relationships with patients (Butt & Ream, 2016; Campion et al., 2007; Latif et al., 2016; Paudyal et al., 2010; Pumtong et al., 2008; Urwin et al., 2016) and GPs (Agomo et al., 2016a; Pumtong et al., 2008) . However, this optimism was not entirely shared by all pharmacists as some were less enthusiastic about extended services and roles (Butterworth et al., 2017; Ogunbayo et al., 2015; Pfleger, McHattie, Diack, McCaig, & Stewart, 2008; Pumtong et al., 2008; Saramunee et al., 2014; Savage et al., 2013; Sohanpal et al., 2016; Wells et al., 2014) . Interestingly, newly registered pharmacists in one study were more enthusiastic towards role expansion than their veteran counterparts (Butterworth et al., 2017) . 
Attitudes towards services/roles
The surgeries are happy that they're not getting so many people coming in [that] we can deal with. We're happy because we're using our professional role and can deal with people quickly and effectively, and the patients are happy because they're getting medicine free of charge.
(Pharmacist, Pumtong et al., 2008) GPs were generally less positive about extended pharmacy services (Atkins et al., 2016; Latif et al., 2016; Porteous & Bond, 2005; Wilcock & Harding, 2007) . Some GPs did not see extended pharmacy services as a priority for them (Wilcock & Harding, 2007) , were not convinced that these services reduced their workload (Atkins et al., 2016; Latif et al., 2016; Porteous & Bond, 2005) and preferred services to be simplified (Porteous & Bond, 2005; Wilcock & Harding, 2007) .
Even when GPs were supportive of community pharmacy services (Blenkinsopp, Tann, Evans, & Grime, 2008; Michie, Cameron, Glasier, & Greed, 2014; Morecroft et al., 2015; Wilcock & Harding, 2007) , this was associated with suggestions that they supervised and authorised pharmacists' activities (Blenkinsopp et al., 2008; Bradley et al., 2012; Maddox, Halsall, Hall, & Tully, 2016; Michie et al., 2014) .
I guess we need to educate them, but I don't feel that's my responsibility…we're going to have to chase it up and make sure they are doing it properly.
(GP, Bradley et al., 2012) 
| Pharmacists' competence and confidence
Pharmacists emphasised the importance of receiving training in order to provide extended services. In some studies, pharmacists mentioned specific training needs such as communication (Horsfield et al., 2011; Morton et al.,2015; Twigg, Wright, Kirkdale, Desborough, & Thornley, 2017; Urwin et al., 2016; Weidmann, MacLure, Marshall, Gray, & Stewart, 2015) and clinical (George, Pfleger, McCaig, Bond, & Stewart, 2006b; Weidmann et al., 2015) skills. In another study, pharmacists recommended interactive training strategies such as visual scenarios/role plays to be able to develop their skills (Sohanpal et al., 2016) . This commonly stemmed from a perceived lack of confidence among pharmacists to provide extended services. In two studies, pharmacists highlighted the need to train locum pharmacists to provide the services on offer as many pharmacies hired them (Akram et al., 2012; Butt & Ream, 2016) . GPs also often doubted pharmacists' competence to provide extended services (Atkins et al., 2016; Blenkinsopp et al., 2008; Bradley et al., 2012; Saramunee et al., 2014) , expressing concerns with their ability to provide services beyond medicines management (Atkins et al., 2016; Blenkinsopp et al., 2008; Bradley et al., 2012; Saramunee et al., 2014) .
There is a lack of training as to how we will approach patients which I say is one of the challenges and how we would approach patients on you know, giving Morton et al., 2015) I would say that given their training neither nurses nor pharmacists should be independent prescribers, I
know its coming but I just don't think they've got the appropriate training.
(GP, Blenkinsopp et al., 2008) 3.6 | Community pharmacy organisations "Community pharmacy organisations" consisted of three subthemes:
"venue and resources", "management" and "workload", which described how working in community pharmacies impacted pharmacists' ability to manage extended services alongside traditional roles.
| Venue and resources
Pharmacists commonly identified a lack of access to patient records as a barrier to providing extended services. This was particularly problematic during out of hours when contacting other staff was difficult (Akram et al., 2012) and increased the likelihood of pharmacists making errors (Savage et al., 2013) . Many pharmacists also voiced concerns over the suitability or availability of pharmacy consultation rooms. Moreover, they perceived that the retail environment of community pharmacies reinforced negative perceptions of patients towards their suitability as providers of extended healthcare services (Hall & Matheson, 2008; Horsfield et al., 2011; Michie et al., 2016; Morton et al., 2015) .
We feel we are out on a limb, and the only, first, contact we have is when we get a prescription through for a controlled drug (CD), and then we are left wondering what it's for. It's like doing a jigsaw and only having half the parts, and trying to make the picture, you know? (Pharmacist, Savage et al., 2013) Health centre would be ideal, they can go and do needles, and they would probably be better placed than us. (Pharmacist, Hall & Matheson, 2008) 
| Management
Pharmacists perceived insufficient management support for extended services, describing pressure to perform services to generate revenue without additional staff or training Wells et al., 2014; Wilcock & Harding, 2008) .
GPs were also critical of the way chain pharmacies were run, being suspicious of commercial motives and a lack of continuity of care for patients (Agomo et al., 2017; Bradley et al., 2012) .
The company is pushing too hard for MURs… The method of payment causes increased pressure to perform.
(Pharmacist, Urban et al., 2016) They want to obviously dispense more items because they get paid for every item, don't they? (GP, Bradley et al., 2012) 
| Workload
Pharmacists frequently mentioned having insufficient time to balance dispensing duties alongside extended services. They acknowledged the need for community pharmacies to employ sufficient pharmacy staff to be able to manage and distribute responsibilities to provide a range of extended services. At times, pharmacists were reluctant to approach patients/provide extended services due to high workload (Evans, Wood, & Carter, 2016; Horsfield et al., 2011; Michie et al., 2016; Sohanpal et al., 2016) which was mainly linked to dispensing duties (Latif et al., 2016; Ogunbayo et al., 2015; Saramunee et al., 2014; Tucker & Stewart, 2015) . Some reconfigured service delivery (Latif et al., 2016; Morton et al., 2015; Sohanpal et al., 2016) or prioritised information provided due to high workload (Sturrock, Preshaw, Hayes, & Wilkes, 2017 ).
There's just not enough pharmacist hours in branch to do everything that pharmacists need to do … because we are busy you kind of don't drive it as much as you could (Pharmacist, Evans et al., 2016) 3.7 | External influences "External influences" focus on factors outside the pharmacy premises which facilitate/hinder the quality and demand of pharmacy services. This theme contains three subthemes: "collaboration with general practitioners", "promotion of services/roles" and "remuneration".
| Collaboration with general practitioners
Despite both pharmacists and GPs acknowledging the importance of collaboration to optimise the provision of extended services, they commonly perceived collaboration to be poor. This perception was influenced by GPs' negative attitudes towards pharmacists (Agomo, Ogunleye, & Portlock, 2016b; Campion et al., 2007; Evans et al., 2016; George et al., 2006b; Latif et al., 2016; Urban et al., 2008; Wilcock & Harding, 2008) , GPs being suspicious of pharmacists' financial motives (Urban et al., 2008) and competition for services (Agomo et al., 2016b; Evans et al., 2016; Latif et al., 2016; Wilcock & Harding, 2008) . Examples of poor engagement included lack of GP availability (Mackridge, Beynon, McVeigh, Whitfield, & Chandler, 2010; Savage et al., 2013) , patient referrals (Latif et al., 2016; Lucas & Blenkinsopp, 2015; Pumtong et al., 2008) and feedback (Akram et al., 2012; Urban et al., 2008) .
The only way I think everything could improve would be to have some way of getting the GPs back into the loop and stressing to them how important it is that patients know about any new medications they've been put on… For any service to work you need to have everybody engaged with the actual service and it's just this problem that the lack of responses from GPs.
(Pharmacist, Lucas & Blenkinsopp, 2015) Both pharmacists and GPs believed that collaboration could be improved by enhancing their relationships (Bradley et al., 2012; Butterworth et al., 2017; Horsfield et al., 2011; Wells et al., 2014) .
However, existing relationships were often perceived as poor and extended services did little to improve this (Bradley et al., 2012; Latif et al., 2016; Paudyal et al., 2010; Pumtong et al., 2008) . Even when GPs viewed relationships with pharmacists to be positive, communication
was not frequent (Porteous & Bond, 2005; Wilcock & Harding, 2007) .
Having a good relationship with the local GP …I think to make referrals easier, to feel like you're part of the team, dealing with it, would obviously help. 
| Promotion of services/roles
Lack of publicity for extended services and roles was commonly cited both by pharmacists and GPs. Some pharmacists perceived promotion to be a governmental duty (Agomo et al., 2016b (Agomo et al., , 2017 Dewsbury, Rodgers, & Krska, 2015) with recommendations through public health campaigns and advertising (Agomo et al., 2016b; Horsfield et al., 2011; Urban et al., 2008) . In one study, pharmacists perceived recommendations by other healthcare professionals, other pharmacists and patients to be the most effective means of raising awareness for medicine-related services . In another study, pharmacists mentioned recruiting patients to smoking cessation services through GP referrals (Sohanpal et al., 2016) .
I think the main thing is just advertising the service… we have leaflets and things like that but somehow the service still doesn't appeal … there will be a percentage of people who will see pharmacists as just dispensers. (Pharmacist, Latif et al., 2016) 
| Remuneration
Pharmacists were undivided in their opinion that remuneration was insufficient for the additional time and work required to perform additional services. Pharmacists were more willing to perform additional services if there were reasonable financial incentives (Horsfield et al., 2011; Latif & Boardman, 2008) . Some argued that unless their pharmacy received remuneration for additional services, they would receive less support from employers (Morton et al., 2015; Ogunbayo et al., 2015; Sohanpal et al., 2016) . Some even suggested being remunerated directly rather than through their employers (Agomo et al., 2016a; Pumtong et al., 2008) . A GP in one study argued that financing extra requirements to provide additional pharmacy services was challenging due to limited NHS funds (Agomo et al., 2017 
| D ISCUSS I ON
This systematic review summarised and compared evidence of both pharmacist and GP views of UK services extending beyond community pharmacy's traditional medicines supply functions published since the introduction of revised contractual frameworks in 2005/2006. This review builds upon the findings of existing systematic reviews looking at pharmacists/GPs views on community pharmacy services in the UK. Unlike existing reviews, this review was not specific to any conditions/services thus covering an extensive range of community pharmacy issues and providing broader implications. Also, this is the first review which compares and contrasts pharmacist and GP views rather than grouping them together as healthcare professional views. Due to a rapid increase in research in this area, particularly in the last few years, this review could cover a wide range of extended services, not in existence at the time of previous reviews (Anderson et al., 2003; Eades et al., 2011) . Moreover, identifying both GPs' and pharmacists' perceptions allowed their views to be compared to better understand how/if their relationship had developed since the introduction of these extended services. However, there was a heavy weighting towards data collected from pharmacists and a relative paucity of research among GPs.
Nonetheless, the findings from this review mirrored earlier reviews eliciting pharmacists' (Anderson et al., 2003; Eades et al., 2011; Hall et al., 2018) and GPs' (Hall et al., 2018 ) views on community pharmacy services in the UK. Those reviews also demonstrated issues with low awareness, time constraints, training needs, venue and resources (Anderson et al., 2003; Eades et al., 2011; Hall et al., 2018) . The importance of community pharmacy integration within the primary care pathway has also been acknowledged previously (Hall et al., 2018) . This suggests that progress in these areas has been slow since the introduction of the revised contractual framework.
Focusing on the UK could be considered both a strength and limitation. It permitted a focus on studies conducted in a single administrative and organisational context. However, it excludes similar community pharmacy advancements in other countries, particularly the United States, Canada, Australia and New Zealand. Nonetheless, pharmacists'
and GPs' attitudes towards extended services in this review reflected international findings, where pharmacists in North America, Asia, Australasia, South America and Europe were also enthusiastic towards the concept of providing extended services (Dosea et al., 2017; Fang, Yang, Feng, Ni, & Zhang, 2011; Kinsey, Scahill, Bye, & Harrison, 2016; Kjome, Sandberg, & Granas, 2008; Schindel et al., 2017) . Moreover, lack of awareness (Bjorkman, Viberg, Rydberg, & Stalsby Lundborg, 2008; Fakih, Marriott, & Hussainy, 2016; Freeman, Cottrell, Kyle, Williams, & Nissen, 2012; Wibowo, Sunderland, & Hughes, 2016) , issues with community pharmacy premises (Babiker, Carson, & Awaisu, 2014; Bjorkman et al., 2008; Donald et al., 2017; Gray, Chamberlain, & Morris, 2016; Hattingh, Emmerton, Ng Cheong Tin, & Green, 2016; Murphy et al., 2016) , lack of management support (Casserlie & Mager, 2016; Donald et al., 2017; Kinsey et al., 2016; Tsao et al., 2016; Watkins, McKee, Hughes, & Pfeiffenberger, 2017) and remuneration (Donald et al., 2017; Gray et al., 2016; Kinsey et al., 2016; Watkins et al., 2017) have also been found in other countries. Many pharmacists elsewhere also stressed the need for sufficient pharmacy staff (Casserlie & Mager, 2016; Gray et al., 2016; Kinsey et al., 2016; Murphy et al., 2016; Tsao et al., 2016) , and pharmacists' (Donald et al., 2017; Jorgenson, Laubscher, Lyons, & Palmer, 2014; Watkins et al., 2017; Wibowo et al., 2016) and GPs' (Bryant, Coster, Gamble, & McCormick, 2009; Dhillon et al., 2015; Tan, Stewart, Elliott, & George, 2014) views confirmed poor engagement between pharmacists and GPs.
This review highlights factors relevant to policy makers for enhancing community pharmacy services for patients within the primary care pathway. For instance, it is apparent that pharmacists are eager to expand their roles but lack the confidence to do so. Implementing regular training and increasing opportunities to apply training could enhance their confidence and reassure them of their competence (Donald et al., 2017; Dosea et al., 2017; Sim, Hattingh, Sherriff, & Tee, 2017; Watkins et al., 2017) . Pharmacists' confidence could also be enhanced by having the ability to witness improved outcomes for patients. Hence, it is important for community pharmacy services to set goals and establish continuity of services with patients to encourage feedback.
In addition, to integrate fully into the patient's primary care pathway, it will be important that pharmacists have access to patients' medical information. This has been recognised to some extent with the implementation of the NHS Summary Care Record in 2016, but this is limited to details on allergies, adverse reactions and medication (current repeats, 12 months' history or acute and 6 months history of discontinued medicines), unless the patient agrees to additional details, such as significant diagnoses .
Pharmacists having access to patients' medical information is particularly useful for them to be able to communicate decisions with GPs and improve safe delivery of pharmacy services when GPs are unavailable (Andalo & Sukkar, 2015; Gibson & Smith, 2016) .
Moreover, publicising extended community pharmacy services could enhance the credibility of such services and establish clearly defined roles for pharmacists, thus increasing public awareness and reducing tensions with GPs (Hall et al., 2018; Hindi et al., 2017) . In particular, patients' perception of GPs as authoritative figures within their primary care pathway (Hindi et al., 2017) suggests that GPs' role in signposting and referral to community pharmacies may be fundamental to increasing service uptake. Yet, GP referrals would depend on community pharmacies having resources to provide consistent, high-quality services. This requires community pharmacies having adequate size, space and privacy alongside fully adequate and soundproof consultation rooms to provide extended services (Hindi et al., 2017) . It is also necessary to assign sufficient pharmacists and support staff on duty to manage extended services together with dispensing prescriptions. Furthermore, developing quality measure assessment tools which evaluate the delivery of extended services among community pharmacies could be another important step towards ensuring high-quality services .
To overcome some of the barriers to better integration of GP and community pharmacy services, existing remuneration models will also need to be reviewed to incentivise both service quality and an alignment of outcome measures used for both GP and community pharmacy contractual arrangements (Bradley, Wagner, Elvey, Noyce, & Ashcroft, 2008; Jacobs, Johnson, & Hassell, 2018; Jacobs et al., 2017) . Incentivising GP referrals and remunerating joint working between community pharmacists and GPs could strengthen integration (Bradley et al., 2008; Hann et al., 2017; Jacobs et al., 2017) . In addition, GPs inclination to recommend patients to community pharmacy services relies on them having confidence in the pharmacist's ability to provide a valuable and competent service. Implementing more multidisciplinary team activities which require mutual responsibilities and shared decision-making could strengthen solidarity between pharmacists and GPs and increase GPs confidence in pharmacists' abilities (Bradley, Ashcroft, & Crossley, 2018; Braithwaite et al., 2016) . More research is needed to explore how GPs confidence in community pharmacists could be improved.
| CON CLUS ION
GPs' awareness of community pharmacy services was low, and while pharmacists were optimistic about the potential value of extended services, they believed there were a number of barriers to successful implementation and integration. GPs were more cautious, and collaborations between pharmacists and GPs were found to remain poor despite the introduction of extended services which required additional communication. Future research should explore different approaches to raise awareness for pharmacy services and better understand how pharmacists and GPs could achieve better collaboration
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